As a member of the founding team of Vetsource, Andrew has been intimately involved in shaping the strategic direction of Vetsource and has held many positions in the company since its inception in 2005. His current focus is on operational efficiencies and advancements, as well as regulatory compliance.
Andrew has also directed business operations as COO for Scott Barber, Inc., acted as Director of Clinical Operations for Pharmatech, Inc. and was co-founder of Premier Veterinary Hospitals, Inc. He has held many pharmaceutical related positions in the industry including serving as a Scientific Manager for Teva (NASDAQ:TEVA) and as a Scientific Liaison for Bristol-Myers Squibb (NYSE:BMY).
Andrew earned a Master’s Degree and a Ph.D. from Colorado State University and was the Leon-Goldberg Fellow in Pharmacology and Toxicology at the Bowman Grey School of Medicine, Wake Forest University. He also worked as a scientist for Targacept (NASDAQ:TRGT), a biopharmaceutical company.
Andrew and his family live near Portland, Oregon with their two cats, Darwin and Bella, and pup, Curie.